packageBegelomab

begelomab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Begelomab is a monoclonal antibody with immunosuppressive activity investigated for graft-versus-host disease in patients undergoing hematopoietic stem cell transplantation. It remains investigational; its marketing application in the European Union was withdrawn, so it is not an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q85125058 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:begelomab
ATC codes:L04AA35, L04AG07
DrugBank:DB13241
Wikidata:Q85125058

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown